DBPR108
DBPR108 Basic information
- Product Name:
- DBPR108
- Synonyms:
-
- DBPR108
- CS-1591
- DBPR-108;DBPR 108
- 2-Pyrrolidinecarbonitrile, 1-[2-[[1,1-dimethyl-3-oxo-3-(1-pyrrolidinyl)propyl]amino]acetyl]-4-fluoro-, (2S,4S)-
- Inhibitor,DBPR108,inhibit,DBPR-108,DPP,Dipeptidyl Peptidase,DBPR 108
- DBPR108, 10 mM in DMSO
- Prusogliptin
- (2S,4S)-4-Fluoro-1-(2-((2-methyl-4-oxo-4-(pyrrolidin-1-yl)butan-2-yl)amino)acetyl)pyrrolidine-2-carbonitrile
- CAS:
- 1186426-66-3
- MF:
- C16H25FN4O2
- MW:
- 324.39
- Mol File:
- 1186426-66-3.mol
DBPR108 Chemical Properties
- Boiling point:
- 557.9±50.0 °C(Predicted)
- Density
- 1.20±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO : ≥ 25 mg/mL (77.07 mM)
- form
- Solid
- pka
- 7.63±0.30(Predicted)
- color
- White to off-white
DBPR108 Usage And Synthesis
Uses
DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM; no inhibition on DDP8 and DPP9. IC50 value: 15 nM [1] Target: DPP4 inhibitor DBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than 3000-fold selectivity over DPP8 DPP9, FAP and DPP-II. TThe in vivo effects of DBPR108, including inhibition of plasma DPP-IV activity and suppression of blood glucose elevation, were also demonstrated. DBPR108 is a potent, selective, long-acting and safe DPP-IV inhibitor as a potential treatment of type 2 diabetes mellitus.
References
[1] Yeh TK, et al. (2S,4S)-1-[2-(1,1-dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV. Bioorg Med Chem Lett. 2010 Jun DOI:10.1016/j.bmcl.2010.04.124
DBPR108Supplier
- Tel
- 025-83697070
- info@chemlin.com.cn
- Tel
- 021-58950125
- info@chemexpress.com
- Tel
- +86-21-5821 5861
- sales@letopharm.com
- Tel
- 021-52996696,15000506266 15000506266
- Tel
- 020-61288194 61288195
- 505721671@qq.com